Insider Transactions in Q4 2022 at Keros Therapeutics, Inc. (KROS)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Nov 29 2022	Tomer Kariv	SELL Exercise of in-the-money or at-the-money derivatives securities	Indirect	7,176 -0.15%	-
Nov 29 2022	Ran Nussbaum	SELL Exercise of in-the-money or at-the-money derivatives securities	Indirect	7,176 -0.15%	-
Nov 29 2022	Pontifax Management 4 G.P. (2015) Ltd. > 10% Shareholder	SELL Exercise of in-the-money or at-the-money derivatives securities	Indirect	7,176 -0.15%	-

Receive a notification when an Institution or Guru buys or sells KROS shares.

Notify only if

Value

Get notified when an Keros Therapeutics, Inc. insider buys or sells KROS shares.

Notify only if

Operation

Value

Type

Receive news related to Keros Therapeutics, Inc.